Skip to content
Shionogi
-
Shionogi secures USD482M BARDA contract for US antibiotic manufacturing
The contract includes multiyear options that could ultimately deliver up to USD 482 million if exercised, enabling Shionogi to establish a dedicated manufacturing facility in the United States.
-
Shionogi increases stake in ViiV Healthcare as Pfizer exits HIV venture in USD2.13B deal
The transaction marks the end of Pfizer’s involvement with ViiV Healthcare, as the American pharmaceutical giant sells its entire 11.7% stake in the company.